$ALLR

$0.92 +$0.00 (0.54%) Close

$ALLR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ALLR Management Team

Mr. Thomas Jensen

Chief Executive Officer

Director

Age 46

Compensation $791.6K USD

Sex Male

Dr. Steen Knudsen

Chief Scientific Officer

Age 64

Compensation $197.3K USD

Sex Male

Dr. Jeremy Graff

President

Chief Development Officer

Age 55

Compensation $444.2K USD

Sex Male

Mr. Gerald Mclaughlin

Independent Chairman of the Board

Age 57

Compensation $105.5K USD

Sex Male

Mr. Jeffrey Ervin

Chief Financial Officer

Age 48

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Thomas Jensen Chief Executive Officer Director	46	$791.6K USD	Male
Dr. Steen Knudsen Chief Scientific Officer	64	$197.3K USD	Male
Dr. Jeremy Graff President Chief Development Officer	55	$444.2K USD	Male
Mr. Gerald Mclaughlin Independent Chairman of the Board	57	$105.5K USD	Male
Mr. Jeffrey Ervin Chief Financial Officer	48	-	Male

Board of Directors

From the proxy statement filed Apr 30, 2026

Directors

serving now

Independent

3 of 4

stated in the proxy

Average tenure

3.0 years

from year joined

CEO also chairs the board

Gerald W. McLaughlin

Director	Age	On board	Independent	Committees	Other public boards	Pay
Jesper Hoiland	65	2025 1 year	Independent	Audit Committee Compensation Committee Nominating and Corporate Governance Committee	SciBase Holding AB (chairman), ALK-Abelló A/S (director)	Not stated
Gerald W. McLaughlin Board chair	58	2022 4 years	Independent	Audit Committee · Chair	Sonoma Pharmaceuticals, Inc.	Not stated
Laura E. Benjamin	60	2023 3 years	Independent	Compensation Committee	None stated	Not stated
Thomas H. Jensen CEO	47	2022 4 years	Not independent	None stated	None stated	Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$ALLR Management Team

Mr. Thomas Jensen

Dr. Steen Knudsen

Dr. Jeremy Graff

Mr. Gerald Mclaughlin

Mr. Jeffrey Ervin

Board of Directors

Related-party transactions

No related-party transactions disclosed